ChemoCentryx Competitors and Similar CompaniesClear all

ChemoCentryx's competitors and similar companies include NATCO Pharma and Turning Point Therapeutics.
ChemoCentryx
ChemoCentryx
ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer.
NATCO Pharma
NATCO Pharma
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
Turning Point Therapeutics
Turning Point Therapeutics
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
Founding Date
Founding Date
1997
Founding Date
1981
Founding Date
2013
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
San Carlos, US HQ
Locations
Hyderabad, IN HQ
Central Hope Town, IN
Chennai, IN
Hyderabad, IN
Santola, IN
Vijayapuri North, IN
Locations
San Diego, US HQ
Employees
Employees
51
Employees
4,016
Employees
474% decrease

Financial

Revenue (est.)
Revenue (est.)
$32.2m (FY, 2021)
Revenue (est.)
₹40.8b (FY, 2026)
Revenue (est.)
$30.8m (FY, 2021)
Cost of goods
Cost of goods
$302k (FY, 2021)
Cost of goods
₹6.9b (FY, 2026)
Cost of goods
N/A
Gross profit
Gross profit
$31.9m (FY, 2021)
Gross profit
₹36.9b (FY, 2026)
Gross profit
N/A
Net income
Net income
($131.8m) (FY, 2021)
Net income
₹13.7b (FY, 2026)
Net income
($236.6m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 149.5m
Total funding raised
N/A
Total funding raised
$ 144.4m
For sources of this data, please see the company profile

View Company Profiles

NATCO Pharma
HQ
Hyderabad, IN
Employees
4,016

NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).

View company
Turning Point Therapeutics
HQ
San Diego, US

Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.

View company